News

Researchers have taken a closer look at how breast cancer develops and have identified an RNA molecule that can suppress cancer formation.

A study carried out at CNIO in collaboration with Korean researchers proposes a new type of cancer predisposition genes and suggests further mechanisms of action for those already known.

Potential "cells of origin" that grow into breast cancer in people with a faulty BRCA2 gene have been identified, and researchers have shown they have the potential to be targeted with drugs.

Researchers have identified a novel mechanism surrounding an immune checkpoint inhibitor that may help improve cancer treatment.

Northwestern Medicine investigators have identified a previously unknown regulator of tumor immune evasion, which may help improve the efficacy of current and future anti-tumor immunotherapies.

The research, which was conducted on mice, demonstrates how these tiny nanomachines are propelled by urea present in urine and precisely target the tumour, attacking it with a radioisotope carried on their surface.

People with obesity are more likely to have a benign blood condition called monoclonal gammopathy of undetermined significance that often precedes multiple myeloma.

A novel pharmaceutical compound that kills leukemia and lymphoma cells has been identified, potentially paving the way to new forms of therapy.

Researchers have discovered that a type of immune cell in the human body known to be important for allergy and other immune responses can also attack cancer.

Researchers developed a drinkable, carbon monoxide-infused foam that boosted the effectiveness of the therapy, known as autophagy inhibition, in mice and human cells.